Cargando…
Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
BACKGROUND & OBJECTIVE: Bacterial, contamination of blood components are a significant risk for transfusion reactions. Inherently, platelet concentrates (PCs) are vulnerable to bacterial contamination, due to the storage condition of processed PCs at room temperature, which provide very suitable...
Autores principales: | Razjou, Farhad, Dabir Moghaddam, Abolfazl, Karimi, Gharib, Zadsar, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Pathology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831066/ https://www.ncbi.nlm.nih.gov/pubmed/29515632 |
Ejemplares similares
-
Toxoplasma and Blood Transfusion
por: KARIMI, Gharib, et al.
Publicado: (2014) -
Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021) -
Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions
por: van Osch, Thijs L. J., et al.
Publicado: (2022) -
Prevalence of risk factors for platelet transfusion refractoriness in multitransfused hemato-oncological patients at tertiary care center in North India
por: Kumawat, Vijay, et al.
Publicado: (2015) -
Stem Cells in Hemato-Oncology
por: Damodar, S
Publicado: (2006)